Intriguingly, FRMPD1 demonstrates tissue-specific functional duality: it suppresses lung cancer via Hippo pathway activation yet drives HCC proliferation, highlighting the complexity of cancer signaling plasticity and metabolic reprogramming across tissue microenvironments [38]. This evidence concerns the gene FRMPD1 and lung cancer.